Brooklyn Investment Group Takes $35,000 Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Brooklyn Investment Group acquired a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 3,927 shares of the pharmacy operator’s stock, valued at approximately $35,000.

Other hedge funds also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. lifted its stake in Walgreens Boots Alliance by 43.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after acquiring an additional 3,329,857 shares during the period. Altrius Capital Management Inc lifted its stake in Walgreens Boots Alliance by 76.6% in the third quarter. Altrius Capital Management Inc now owns 440,483 shares of the pharmacy operator’s stock worth $3,947,000 after acquiring an additional 190,996 shares during the period. PNC Financial Services Group Inc. lifted its stake in Walgreens Boots Alliance by 23.4% in the third quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator’s stock worth $3,050,000 after acquiring an additional 64,586 shares during the period. Sasco Capital Inc. CT lifted its stake in Walgreens Boots Alliance by 13.6% in the third quarter. Sasco Capital Inc. CT now owns 1,041,440 shares of the pharmacy operator’s stock worth $9,331,000 after acquiring an additional 124,950 shares during the period. Finally, Van ECK Associates Corp lifted its stake in Walgreens Boots Alliance by 21.3% in the third quarter. Van ECK Associates Corp now owns 322,984 shares of the pharmacy operator’s stock worth $3,019,000 after acquiring an additional 56,725 shares during the period. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA opened at $9.02 on Friday. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $27.05. The company’s 50 day moving average is $9.14 and its 200 day moving average is $11.30. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67. The company has a market cap of $7.80 billion, a PE ratio of -0.90, a price-to-earnings-growth ratio of 1.19 and a beta of 0.69.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. During the same quarter in the prior year, the company earned $0.67 EPS. Walgreens Boots Alliance’s quarterly revenue was up 5.9% on a year-over-year basis. On average, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be given a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 annualized dividend and a yield of 11.09%. Walgreens Boots Alliance’s dividend payout ratio is presently -9.99%.

Analysts Set New Price Targets

WBA has been the subject of a number of recent research reports. Barclays boosted their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 16th. Morgan Stanley reduced their target price on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. Evercore ISI boosted their target price on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a report on Wednesday, October 16th. UBS Group boosted their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Finally, TD Cowen cut their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $12.88.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.